Cannabis
Johns Hopkins trial finds edibles plus alcohol can amplify simulated driving impairment; sobriety tests often miss it
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
A controlled Johns Hopkins Medicine study found that taking cannabis edibles with alcohol can produce greater and longer-lasting impairment on a driving simulator than using either substance alone, while standardized field sobriety tests frequently failed to flag cannabis-related impairment unless alcohol levels were high.
Curaleaf Holdings, Inc. conducted its first quarter 2026 earnings conference call on May 5, 2026. Company executives including CEO Boris Jordan and CFO Ed Kremer participated alongside analysts from major firms. The call included standard forward-looking statement disclaimers.
Ti AI ṣe iroyin Ti ṣayẹwo fun ododo
Researchers at Stellenbosch University say they have found the first evidence of rare phenolic compounds known as flavoalkaloids in cannabis leaves, after profiling dozens of plant chemicals across three commercially grown strains.
A comprehensive review of clinical trials suggests that cannabis products high in THC may provide modest, short-term relief for chronic pain, especially neuropathic types, but with notable side effects. In contrast, CBD-dominant products offer no clear advantages. Researchers call for more long-term studies to assess safety and efficacy.
Ti AI ṣe iroyin Ti ṣayẹwo fun ododo
Laboratory research led by scientists at Khon Kaen University indicates that cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), two key cannabis compounds, can slow the growth and spread of ovarian cancer cells in vitro, particularly when used together in a 1:1 ratio, while causing relatively limited damage to healthy cells. The early-stage findings, reported in Frontiers in Pharmacology, suggest a potential avenue for future ovarian cancer treatments but are far from clinical use.
Researchers from UC San Diego and 23andMe have discovered genetic links to cannabis use behaviors, connecting them to over 100 health traits. The study, published on October 13, 2025, in Molecular Psychiatry, highlights two key genes and could inform prevention of cannabis use disorder. It analyzed data from nearly 132,000 participants to explore early-stage risks.
Ti AI ṣe iroyin
A new study presented at the American College of Surgeons Clinical Congress found that nearly 42% of drivers killed in crashes in Ohio had active THC in their blood, with levels far exceeding legal limits. The prevalence remained unchanged even after recreational cannabis legalization in 2023. Researchers urge stronger public messaging on the risks of driving after marijuana use.
Todd Blanche reclassifies state-authorized medical marijuana
March 20, 2026 04:38Large study finds no evidence cannabis treats anxiety, depression or PTSD
March 19, 2026 22:51Consumer products containing cannabis-derived CBN to be banned from June
March 10, 2026 15:28Study reveals THC impairs multiple memory types in users
February 18, 2026 02:17Study shows cannabis drinks halve alcohol use
December 11, 2025 04:28Stressed rats keep returning to cannabis, study finds
November 29, 2025 13:36Cannabis store clusters associated with higher emergency visits in Ontario study
November 28, 2025 02:55New ICD code tracks rising cannabis hyperemesis syndrome cases
November 16, 2025 08:51Study reveals cannabis and tobacco co-use disrupts brain's bliss molecule
October 24, 2025 17:30Colorado audit finds many cannabis flower THC labels overstated; concentrates largely accurate